A Straightforward Three-Component Synthesis of α-Amino Esters Containing a Phenylalanine or a Phenylglycine Scaffold
摘要:
A range of alpha-amino esters has been synthesized in good to high yields using a straightforward three-component reaction among preformed or in situ generated aromatic or benzylic organozinc reagents, primary or secondary amines, and ethyl glyoxylate. The procedure, which is characterized by its simplicity, allows the concise synthesis of esters bearing a phenylglycine or a phenylalanine scaffold.
[EN] PHENYLALANINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCERS<br/>[FR] DÉRIVÉS DE PHÉNYLALANINE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE CANCERS
申请人:UNIV PARIS VAL DE MARNE
公开号:WO2019185907A1
公开(公告)日:2019-10-03
The present invention relates to the field of medicine, in particular of oncology. Especially, it provides new compounds useful in the treatment of various cancers. The present invention relates more particularly to methods for the treatment of cancer with IL4I1 expressing cells.
A concise three-component synthesis of α-amino esters derived from phenylglycine and phenylalanine
作者:Caroline Haurena、Stéphane Sengmany、Paul Huguen、Erwan Le Gall、Thierry Martens、Michel Troupel
DOI:10.1016/j.tetlet.2008.09.137
日期:2008.12
alpha-Amino esters have been synthesized using a straightforward three-component reaction among preformed or in situ-generated aromatic or benzylic organozinc reagents, primary or secondary amines and ethyl glyoxylate. The procedure, which is characterized by its simplicity, allows the concise synthesis of phenylglycine and phenylalanine derivatives, (C) 2008 Elsevier Ltd. All rights reserved.
PHENYLALANINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCERS
申请人:UNIVERSITE PARIS EST CRETEIL VAL DE MARNE
公开号:US20210023034A1
公开(公告)日:2021-01-28
The present invention relates to the field of medicine, in particular of oncology. Especially, it provides new compounds useful in the treatment of various cancers. The present invention relates more particularly to methods for the treatment of cancer with IL4I1 expressing cells.